Foghorn Therapeutics at SLAS2027

Jan 30 – Feb 3, 2027 San Diego, CA ~7.6k attendees Website

Foghorn Therapeutics brings 1 presentation to SLAS2027 in San Diego. It develops medicines targeting the chromatin regulatory system in cancer. Its talk is about induced proximity for transcriptional regulation.

OrganizationSLAS2027 Attendance
Biopharma
Biotech developing medicines that target the chromatin regulatory system in cancer.
Talk
Mon Feb 1
10–10:25am
Part of Expanding Induced Proximity Paradigms Beyond Traditional Targeted Protein Degradation (TPD)
Induced Proximity for Transcriptional Regulation
Ballroom 6E
New modalities

Explore the full SLAS2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Diego. Leave your work email and we’ll be in touch.

Privacy

Download the full SLAS2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Foghorn Therapeutics

Tell us what you sell and we’ll find the people at Foghorn Therapeutics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Society for Laboratory Automation and Screening. Organization details are derived from SLAS’s published exhibitor list and event scheduler. Submit a correction